Lung function changes related to diabetes mellitus

Diabetes Technology and Therapeutics

Volumn 9, Issue SUPPL. 1, 2007, Pages

  Hsia, Connie C W ^a   Raskin, Philip ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

AUTONOMIC NEUROPATHY; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DISEASE COURSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; FORCED EXPIRATORY VOLUME; HUMAN; LUNG BLOOD VESSEL; LUNG DIFFUSION CAPACITY; LUNG DISEASE; LUNG FUNCTION; LUNG FUNCTION TEST; MICROVASCULATURE; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

CAPILLARIES; DIABETES MELLITUS; DIABETIC NEUROPATHIES; FEMALE; HUMANS; LUNG; MALE; PULMONARY ALVEOLI; PULMONARY CIRCULATION; RESPIRATORY FUNCTION TESTS;

EID: 34250710080     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2007.0227     Document Type: Conference Paper

References (85)

1. Rosenstock J, Friberg T, Raskin P: Effect of glycemic control on microvascular complications in patients with Type I diabetes mellitus. Am J Med 1986;81:1012-1017.
2. Reichard P, Berglund B, Britz A, Cars I, Nilsson BY, Rosenqvist U: Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years. J Intern Med 1991;230:101-108.
3. Chase HP, Jackson WE, Hoops SL, Cockerham RS, Archer PG, O'Brien D: Glucose control and the renal and retinal complications of insulin-dependent diabetes. JAMA 1989;261:1155-1160.
4. Hansen LA, Prakash UBS, Colby TV: Pulmonary complications in diabetes mellitus. Mayo Clin Proc 1989;64:791-799.
5. Williams JG, Morris AI, Hayter RC, Ogilvie CM: Respiratory responses of diabetics to hypoxia, hypercapnia and exercise. Thorax 1984;39:529-534.
6. Brassard P, Ferland A, Bogaty P, Desmeules M, Jobin J, Poirier P: Influence of glycemic control on pulmonary function and heart rate in response to exercise in subjects with type 2 diabetes mellitus. Metabolism 2006;55:1532-1537.
7. Weisbrod CJ, Eastwood PR, O'Driscoll G, Green DJ: Abnormal ventilatory responses to hypoxia in Type 2 diabetes. Diabet Med 2005;22:563-568.
8. O'Donnell CR, Friedman LS, Russomanno JH, Rose RM: Diminished perception of inspiratory-resistive loads in insulin-dependent diabetics. N Engl J Med 1988;319:1369-1373.
9. Antonelli Incalzi R, Fuso L, Pitocco D, Basso S, Trove A, Longobardi A, Calcagni ML, Giordano A, Ghirlanda G: Decline of neuroadrenergic bronchial innervation and respiratory function in type 1 diabetes mellitus: a longitudinal study. Diabetes Metab Res Rev 2006;23:311-316.
10. Scano G, Filippelli M, Romagnoli I, Mancini M, Misuri G, Duranti R, Rosi E: Hypoxic and hypercapnic breathlessness in patients with type I diabetes mellitus. Chest 2000;117:960-967.
11. Sandler M, Bunn AE, Stewart RI: Pulmonary function in young insulin-dependent diabetic subjects. Chest 1986;90:670-675.
12. Lange P, Parner J, Schnohr P, Jensen G: Copenhagen City Heart Study: longitudinal analysis of ventilatory capacity in diabetic and nondiabetic adults. Eur Respir J 2002;20:1406-1412.
13. Ramirez LC, Dal Nogare A, Hsia CCW, Arauz C, Strowig S, Schnurrbreen L, Raskin P: Relationship between diabetes control and pulmonary function in insulin dependent diabetes mellitus. Am J Med 1991;91:371-376.
14. Niranjan V, McBrayer DG, Ramirez LC, Raskin P, Hsia CCW: Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus. Am J Med 1997;103:504-513.
15. Schuyler MR, Niewoehner DE, Inkley SR, Kohn R: Abnormal lung elasticity in juvenile diabetes mellitus. Am Rev Respir Dis 1976;113:37-41.
16. Schnapf BN, Banks RA, Silverstein JH, Rosenbloom AL, Chesrown SE, Loughlin GM: Pulmonary function in insulin-dependent diabetes mellitus with limited joint mobility. Am Rev Respir Dis, 1984;130:930-932.
17. Davis WA, Knuiman M, Kendall P, Grange V, Davis TM: Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2004;27:752-757.
18. Walter RE, Beiser A, Givelber RJ, O'Connor GT, Gottlieb DJ: Association between glycemic state and lung function: the Framingham Heart Study. Am J Respir Crit Care Med 2003;167:911-916.
19. Zanen P, Folgering H, Lammers JW: Flow-volumes indices as means to discriminate between intra- and extrapulmonary restrictive disease. Respir Med 2005;99:825-829.
20. van Gent R, Brackel HJ, de Vroede M, van der Ent CK: Lung function abnormalities in children with type I diabetes. Respir Med 2002;96:976-978.
21. Mancini M, Filippelli M, Seghieri G, Iandelli I, Innocenti F, Duranti R, Scano G: Respiratory muscle function and hypoxic ventilatory control in patients with type I diabetes. Chest 1999;115:1553-1562.
22. Brownlee M, Vlassara H, Cerami A: Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 1984;101:527-537.
23. Hamlin CR, Kohn RR, Luschin JH: Apparent accelerated aging of human collagen in diabetes mellitus. Diabetes 1975;24:902-904.
24. Ofulue AF, Thurlbeck WM: Experimental diabetes and the lung. II. In vivo connective tissue metabolism. Am Rev Respir Dis 1988;138:284-289.
25. Hsia CC, Raskin P: The diabetic lung: relevance of alveolar microangiopathy for the use of inhaled insulin. Am J Med 2005;118:205-211.
26. Litonjua AA, Lazarus R, Sparrow D, Demolles D, Weiss ST: Lung function in type 2 diabetes: the Normative Aging Study. Respir Med 2005;99:1583-1590.
27. Lawlor DA, Ebrahim S, Smith GD: Associations of measures of lung function with insulin resistance and Type 2 diabetes: findings from the British Women's Heart and Health Study. Diabetologia 2004;47:195-203.
28. Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, Brancati FL: Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2005;28:1472-1479.
29. Ford ES, Mannino DM: Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care 2004;27:2966-2970.
30. Klein BE, Moss SE, Klein R, Cruickshanks KJ: Peak expiratory flow rate: relationship to risk variables and mortality: the Wisconsin Epidemiologic Study of diabetic retinopathy. Diabetes Care 2001;24:1967-1971.
31. Vlahakis NE, Hubmayr RD: Response of alveolar cells to mechanical stress. Curr Opin Crit Care 2003;9:2-8.
32. O'Donnell CP, Tankersley CG, Polotsky VP, Schwartz AR, Smith PL: Leptin, obesity, and respiratory function. Respir Physiol 2000;119:163-170.
33. Sin DD, Man SF: Impaired lung function and serum leptin in men and women with normal body weight: a population based study. Thorax 2003;58:695-698.
34. Roughton FJW, Forster RE: Relative importance of diffusion and chemical reaction rates in determining the rate of exchange of gases in the human lung, with special reference to true diffusing capacity of the pulmonary membrane and volume of blood in lung capillaries. J Appl Physiol 1957;11:290-302.
35. Hsia CCW: Recruitment of lung diffusing capacity: update of concept and application. Chest 2002;122:1774-1783.
36. Sandler M, Bunn AE, Stewart RI: Cross-section study of pulmonary function in patients with insulin-dependent diabetes mellitus. Am Rev Respir Dis 1987;135:223-229.
37. Chance WW, Rhee C, Dane DM, Merrikh A, Phansalkar AR, Yilmaz C, Pruneda ML, Raskin P, Hsia CCW: Impaired pulmonary function in patients with type-2 diabetes mellitus [abstract]. Proc Am Thorac Soc 2006;3:A721.
38. Asanuma Y, Fujiya S, Ide H, Agishi Y: Characteristics of pulmonary function in patients with diabetes mellitus. Diabetes Res Clin Pract 1985;1:95-101.
39. Weir DC, Jennings PE, Hendy MS, Barnett AH, Burge PS: Transfer factor for carbon monoxide in patients with diabetes with and without microangiopathy. Thorax 1988;43:725-726.
40. Fuso L, Cotroneo P, Basso S, De Rosa M, Manto A, Ghirlanda G, Pistelli R: Postural variations of pulmonary diffusing capacity in insulin-dependent diabetes mellitus. Chest 1996;110:1009-1013.
41. Sexton WL, Poole DC, Mathieu-Costello O: Microcirculatory structure-function relationships in skeletal muscle of diabetic rats. Am J Physiol 1994;266:H1502-H1511.
42. Weibel ER: Morphometric and stereological methods in respiratory physiology, including fixation techniques. In: Otis AB, ed. Techniques in the Life Sciences, Respiratory Physiology. New York: Elsevier, 1984:1-35.
43. Takeda S, Hsia CCW, Wagner E, Ramanathan M, Estrera AS, Weibel ER: Compensatory alveolar growth normalizes gas exchange function in immature dogs after pneumonectomy. J Appl Physiol 1999;86:1301-1310.
44. Vracko R, Thorning D, and Huang TW: Basal lamina of alveolar epithelium and capillaries: quantitative changes with aging and in diabetes mellitus. Am Rev Respir Dis 1979;120:973-983.
45. Kodolova IM, Lysenko LV, Saltykov BB: [Changes in the lungs in diabetes mellitus]. Arkh Patol 1982;44:35-40.
46. Camerini-Davalos RA, Velasco C, Glasser M, Bloodworth JM Jr: Drug-induced reversal of early diabetic microangiopathy. N Engl J Med 1983;309:1551-1556.
47. Siperstein MD, Unger RH, Madison LL: Studies of muscle capillary basement membranes in normal subjects, diabetic and prediabetic patients. J Clin Invest 1968;47:1973-1999.
48. Raskin P, Marks JF, Burns H Jr, Plumer ME, Siperstein MD: Capillary basement membrane width in diabetic children. Am J Med 1975;58:365-372.
49. Raskin P, Pietri AO, Unger R, Shannon WA Jr: The effect of diabetic control on the width of skeletal muscle capillary basement membrane in patients with type I diabetes mellitus. N Engl J Med 1983;309:1546-1550.
50. Popov D, Hasu M, Costache G, Stern D, Simionescu M: Capillary and aortic endothelia interact in situ with nonenzymatically glycated albumin and develop specific alterations in early experimental diabetes. Acta Diabetol 1997;34:285-293.
51. Pascariu M, Bendayan M, Ghitescu L: Correlated endothelial caveolin overexpression and increased transcytosis in experimental diabetes. J Histochem Cytochem 2004;52:65-76.
52. Brownlee M: Advanced protein glycosylation in diabetes and aging. Annu Rev Med 1995;46:223-234.
53. Sugahara K, Ushijima K, Morioka T, Usuku G: Studies of the lung in diabetes mellitus. I. Ultrastructural studies of the lungs in alloxan-induced diabetic rats. Virchows Arch A Pathol Anat Histol 1981;390:313-324.
54. Sugahara K, Iyama K, Sano K, Morioka T: Differential expressions of surfactant protein SP-A, SP-B, and SP-C mRNAs in rats with streptozotocin- induced diabetes demonstrated by in situ hybridization. Am J Respir Cell Mol Biol 1994;11:397-404.
55. Lee YS: Electron microscopic studies on the alveolar-capillary barrier in the patients of chronic pulmonary edema. Jpn Circ J 1979;43:945-954.
56. Townsley MI, Fu Z, Mathieu-Costello O, West JB: Pulmonary microvascular permeability. Responses to high vascular pressure after induction of pacing-induced heart failure in dogs. Circ Res 1995;77:317-325.
57. Guazzi M, Brambilla R, Pontone G, Agostoni P, Guazzi MD: Effect of non-insulin-dependent diabetes mellitus on pulmonary function and exercise tolerance in chronic congestive heart failure. Am J Cardiol 2002;89:191-197.
58. Guazzi M, Brambilla R, De Vita S, Guazzi MD: Diabetes worsens pulmonary diffusion in heart failure, and insulin counteracts this effect. Am J Respir Crit Care Med 2002;166:978-982.
59. Guazzi M, Oreglia I, Guazzi MD: Insulin improves alveolar-capillary membrane gas conductance in type 2 diabetes. Diabetes Care 2002;25:1802-1806.
60. Das UN: Insulin: an endogenous cardioprotector. Curr Opin Crit Care 2003;9:375-383.
61. Aye M, Sheedy W, Harrison R, Thompson JS, Morice AH, Masson EA: Pulmonary vasodilation in the rat by insulin in vitro could indicate potential hazard for inhaled insulin. Diabetologia 2003;46:1199-1202.
62. Lim SC, Caballero AE, Smakowski P, LoGerfo FW, Horton ES, Veves A: Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes Care 1999;22:1865-1870.
63. Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, King GL, LoGerfo FW, Horton ES, Veves A: Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 1999;48:1856-1862.
64. Papayianni M, Gourgoulianis KI, Molyvdas PA: Insulin NO-dependent action on airways smooth muscles. Nitric Oxide 2001;5:72-76.
65. Ditzel J: Oxygen transport impairment in diabetes. Diabetes 1976;25:832-838.
66. MacDonald MJ, Bleichman M, Bunn HF: Functional properties of the glycosylated minor components of human adult hemoglobin. J Biol Chem 1979;254:702-707.
67. Babalola RO, Ajayi AA: A cross-sectional study of echocardiographic indices, treadmill exercise capacity and microvascular complications in Nigerian patients with hypertension associated with diabetes mellitus. Diabet Med 1992;9:899-903.
68. Baraldi E, Monciotti C, Filippone M, Santuz P, Magagnin G, Zanconato S, Zacchello F: Gas exchange during exercise in diabetic children. Pediatr Pulmonol 1992;13:155-160.
69. Mandroukas K, Krotkiewski M, Holm G, Stromblad G, Grimby G, Lithell H, Wroblewski Z, Bjorntrop P: Muscle adaptations and glucose control after physical training in insulin-dependent diabetes mellitus. Clin Physiol 1986;6:39-52.
70. Huttunen NP, Lankela SL, Knip M, Lautala P, Kaar ML, Laasonen K, Puukka R: Effect of once-a-week training program on physical fitness and metabolic control in children with IDDM. Diabetes Care 1989;12:737-740.
71. Bernbaum M, Albert SG, Cohen JD, Drimmer A: Cardiovascular conditioning in individuals with diabetic retinopathy. Diabetes Care 1989;12:740-742.
72. Selam JL, Casassus P, Bruzzo F, Leroy C, Slama G: Exercise is not associated with better diabetes control in type 1 and type 2 diabetic subjects. Acta Diabetol 1992;29:11-13.
73. Cruickshanks KJ, Moss SE, Klein R, Klein BE: Physical activity and proliferative retinopathy in people diagnosed with diabetes before age 30 yr. Diabetes Care 1992;15:1267-1272.
74. Saltin B, Blomqvist G, Mitchell JH, Johnson RL Jr, Wildenthal K, Chapman CB: Response to exercise after bed rest and after training. Circulation 1968;37-38:1-78.
75. Hankinson JL, Odencrantz JR, Fedan KB: Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159:179-187.
76. Viegi G, Sherrill DL, Carrozzi L, Di Pede F, Baldacci S, Pistelli F, Enright P: An 8-year follow-up of carbon monoxide diffusing capacity in a general population sample of northern Italy. Chest 2001;120:74-80.
77. Wannamethee SG, Shaper AG, Whincup PH: Body fat distribution, body composition, and respiratory function in elderly men. Am J Clin Nutr 2005;82:996-1003.
78. Alfonso HS, Fritschi L, de Klerk NH, Olsen N, Sleith J, Musk AB: Effects of asbestos and smoking on gas diffusion in people exposed to crocidolite. Med J Aust 2005;183:184-187.
79. Brennan AL, Geddes DM, Gyi KM, Baker EH: Clinical importance of cystic fibrosis-related diabetes. J Cyst Fibros 2004;3:209-222.
80. Milla CE, Billings J, Moran A: Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 2005;28:2141-2144.
81. Milla CE, Warwick WJ, Moran A: Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 2000;162:891-895.
82. Teeter JG, Riese RJ: Dissociation of lung function changes with humoral immunity during inhaled human insulin therapy. Am J Respir Crit Care Med 2006;173:1194-1200.
83. Ceglia L, Lau J, Pittas AG: Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus. Ann Intern Med 2006;145:665-675.
84. Skyler JS, Jovanovic L, Klioze S, Reis J, Duggan W: Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes. Diabetes Care 2007;30:579-585.
85. Dieterle CD, Schmauss S, Arbogast H, Domsch C, Huber RM, Landgraf R: Pulmonary function in patients with type 1 diabetes before and after simultaneous pancreas and kidney transplantation. Transplantation 2007;83:566-569.